Literature DB >> 8032531

Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid.

N Hayashi1, M Furihata, Y Ohtsuki, H Ueno.   

Abstract

Twenty-one Japanese patients with sebaceous carcinoma of the eyelid were investigated for tumour incorporation of human papillomavirus (HPV) types-6, 11, 16, 18, 31, and/or 33 DNA by in situ hybridization with fluorescein isothiocyanate-labelled DNA probes, and for p53 protein accumulation by immunohistochemical analysis with an antibody to p53 protein. Thirteen tumours (61.9%), including 9 cases of multiple infections, were positive for HPV DNA. Positive signal in the nucleus was observed not only in the cancer cells, but also in the cells of surrounding normal sebaceous glands and epidermis. Positive nuclear staining of cancer cells with the antibody to p53 protein was detected in 12 cases (57.1%). p53 protein accumulation was more frequently observed in the clinically advanced cases, occasionally in association with recurrence and/or metastasis. Among the 12 p53-positive cases, 7 were also positive for the presence of HPV DNA. HPV infections exist in a high percentage of sebaceous carcinomas of the eyelid in Japan; the overexpression of p53 protein may be important in both carcinogenesis and progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032531     DOI: 10.1007/bf00191436

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

2.  Biology and biochemistry of papillomaviruses.

Authors:  H Pfister
Journal:  Rev Physiol Biochem Pharmacol       Date:  1984       Impact factor: 5.545

Review 3.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

4.  p53 mutations in basal cell carcinomas.

Authors:  P Rady; F Scinicariello; R F Wagner; S K Tyring
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

5.  High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.

Authors:  M Furihata; K Inoue; Y Ohtsuki; H Hashimoto; N Terao; Y Fujita
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

6.  Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

Authors:  W P Bennett; M C Hollstein; A He; S M Zhu; J H Resau; B F Trump; R A Metcalf; J A Welsh; C Midgley; D P Lane
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

Review 7.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer.

Authors:  M Furihata; Y Ohtsuki; S Ogoshi; A Takahashi; T Tamiya; T Ogata
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

9.  Torre-Muir syndrome. An association with isolated sebaceous carcinoma.

Authors:  R Graham; P McKee; D McGibbon; E Heyderman
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  12 in total

1.  Sebaceous carcinoma of eyelid.

Authors:  Manoranjan Varshney; Kiran Alam; Mehar Aziz; Veena Maheshwari; Kavita Gaur; SyedAli Raza Rizvi
Journal:  BMJ Case Rep       Date:  2011-06-21

2.  Pigmented conjunctival epithelial dysplasia in an HIV positive African: detection of human papillomavirus type 16.

Authors:  K U Loeffler; H Witschel; H Ikenberg; I Wiegering; R Sundmacher
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

3.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Authors:  Graça M Dores; Rochelle E Curtis; Jorge R Toro; Susan S Devesa; Joseph F Fraumeni
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

4.  Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Authors:  Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

5.  Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.

Authors:  Michael R Sargen; Elizabeth K Cahoon; Charles F Lynch; Margaret A Tucker; Alisa M Goldstein; Eric A Engels
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

6.  Periocular sebaceous gland carcinoma: A comprehensive review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Valerie A White
Journal:  Saudi J Ophthalmol       Date:  2013-07

7.  Sebaceous carcinoma arising from sebaceoma.

Authors:  Da Woon Lee; Si Hyun Kwak; Jun Hyuk Kim; Je Yeon Byeon; Hyun Joo Lee; Hwan Jun Choi
Journal:  Arch Craniofac Surg       Date:  2021-04-29

8.  Early onset sebaceous carcinoma.

Authors:  Dongjin Sung; Sara A Kaltreider; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2011-09-05       Impact factor: 2.644

Review 9.  Sebaceous Carcinoma Epidemiology and Genetics: Emerging Concepts and Clinical Implications for Screening, Prevention, and Treatment.

Authors:  Michael R Sargen; Gabriel J Starrett; Eric A Engels; Elizabeth K Cahoon; Margaret A Tucker; Alisa M Goldstein
Journal:  Clin Cancer Res       Date:  2020-09-09       Impact factor: 13.801

10.  c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis.

Authors:  Denny L Cottle; Kai Kretzschmar; Pawel J Schweiger; Sven R Quist; Harald P Gollnick; Ken Natsuga; Satoru Aoyagi; Fiona M Watt
Journal:  Cell Rep       Date:  2013-02-09       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.